CAMG
JAZZ icon

CWA Asset Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

CWA Asset Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Buy
19,619
+109
+0.6% +$23.9K 0.14% 152
2026
Q1 		$3.69M Sell
19,510
-1,232
-6% -$215K 0.13% 174
2025
Q4 		$3.53M Sell
20,742
-1,035
-5% -$159K 0.13% 156
2025
Q3 		$2.87M Sell
21,777
-358
-2% -$42.9K 0.11% 175
2025
Q2 		$2.35M Sell
22,135
-1,507
-6% -$164K 0.1% 186
2025
Q1 		$2.94M Sell
23,642
-2,963
-11% -$387K 0.14% 142
2024
Q4 		$3.28M Sell
26,605
-2,088
-7% -$246K 0.17% 121
2024
Q3 		$3.2M Buy
+28,693
New +$3.14M 0.17% 115
2024
Q1 		$3.57M Buy
+29,651
New +$3.63M 0.22% 101

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CWA Asset Management Group's JAZZ Position: Q2 2026 in Review

CWA Asset Management Group increased its Jazz Pharmaceuticals (JAZZ) stake by 0.56% in Q2 2026, buying an estimated $23.9K and bringing the position to 19,619 shares worth $4.73M. The position accounts for 0.14% of the portfolio, ranked #152.

CWA Asset Management Group first reported a position in JAZZ in Q1 2024 and has held it in 9 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • CWA Asset Management Group held 19,619 shares of Jazz Pharmaceuticals worth $4.73M as of Q2 2026.
  • CWA Asset Management Group bought 109 Jazz Pharmaceuticals shares in Q2 2026, an estimated $23.9K.
  • Jazz Pharmaceuticals made up 0.14% of CWA Asset Management Group's portfolio in Q2 2026, its #152 holding.
  • CWA Asset Management Group first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.